⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,714.56
+0.31%
Nasdaq 100
29,557.37
+0.09%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$216.78
−0.14%
NYSE:TSM
$426.49
+1.49%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,134.44
−0.15%
Brent
$108.36
−0.78%
BTC
$82,306.94
+0.57%
ETH
$2,428.08
+0.95%
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,714.56
+0.31%
Nasdaq 100
29,557.37
+0.09%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$216.78
−0.14%
NYSE:TSM
$426.49
+1.49%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,134.44
−0.15%
Brent
$108.36
−0.78%
BTC
$82,306.94
+0.57%
ETH
$2,428.08
+0.95%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NAS
› NRIX
N
Nurix Therapeutics Inc
NAS:NRIX
Healthcare
CBOEFTSE:MRUT
NASDAQ:NBI
$25.83
+3.59%
Live
In session · ≈
AED 94.84
· Market cap
$2.82B
· Next earnings
Wed 17 Feb
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
Nurix Therapeutics Inc · News · TradingHolo
NRIX news
Headlines tagged to this company
DO
Nurix Therapeutics Price Target Raised to $36.00/Share From $34.00 by HC Wainwright & Co.
Dow Jones Newswires · 4 d ago
TR
HC Wainwright & Co. maintains Buy rating on Nurix Therapeutics, $36 price target
TradingView · 4 d ago
DO
Big Pharma Is Pouring Billions Into a New Class of 'Protein Degrader' Drugs — WSJ
Dow Jones Newswires · 5 d ago
TR
Nurix Therapeutics Director Sold Shares Worth Over $528K
TradingView · 6 d ago
DO
Nurix Therapeutics Price Target Cut to $35.00/Share From $36.00 by RBC Capital
Dow Jones Newswires · 7 d ago
TR
RBC Capital maintains Outperform rating on Nurix Therapeutics, $35 price target
TradingView · 7 d ago
DO
Nurix Therapeutics Is Maintained at Outperform by Oppenheimer
Dow Jones Newswires · 7 d ago
TR
Oppenheimer maintains Outperform rating on Nurix Therapeutics, $32 price target
TradingView · 7 d ago
DO
Nurix Therapeutics Is Maintained at Buy by Truist Securities
Dow Jones Newswires · 7 d ago
TR
Truist Securities maintains Buy rating on Nurix Therapeutics, $33 price target
TradingView · 7 d ago
DO
Nurix Therapeutics Is Maintained at Outperform by Baird
Dow Jones Newswires · 7 d ago
DO
Nurix Therapeutics Price Target Maintained With a $34.00/Share by Needham
Dow Jones Newswires · 7 d ago
TR
Nurix Therapeutics 3Q 2026: Revenue $673.1M, EPS $4.73— 10-Q Summary
TradingView · 7 d ago
TR
Needham reiterates Buy rating on Nurix Therapeutics, $34 price target
TradingView · 7 d ago
TR
Nurix Therapeutics reports Q3 2026 revenue $673.1M, net income $549.8M and $1.1B cash
TradingView · 7 d ago
TR
Nurix Therapeutics, Inc. Stock 12‑Month Price Target Raised to $34.36, Implies 55% Upside
TradingView · 7 d ago
RE
Nurix Therapeutics Q3 swings to profit on Roche collaboration
Reuters · 8 d ago
DO
Nurix Therapeutics 3Q Rev $673.1M >NRIX
Dow Jones Newswires · 8 d ago
DO
Nurix Therapeutics 3Q EPS $4.73 >NRIX
Dow Jones Newswires · 8 d ago
DO
Nurix Therapeutics 3Q Net $549.8M >NRIX
Dow Jones Newswires · 8 d ago
More news →